Delivery Order SPE2DB20D3103-SPE2DB25FQ0P7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,569.12 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) on August 6, 2025, with completion targeted for August 7, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate office location in Conshohocken, PA 19428. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,645.80 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone otic suspension (7.5mL) on November 20, 2025, with completion expected by November 21, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle valued through...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) with a ceiling value of $17,136.44. This is a firm fixed-price, non-set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,195.90 to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with performance completion scheduled for June 4, 2025. This non-competitive delivery order utilizes firm fixed price pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ml with a ceiling value of $2,177.06. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. The contract is scheduled for ultimate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,307.60 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone otic suspension in 7.5ml units. The contract was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, and will be performed in Conshohocken, Pennsylvania. This award represents a firm fixed-price, non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5ML) with a ceiling value of $1,190.89. This competitively awarded, firm fixed-price delivery order was executed on August 1, 2025, with an ultimate completion date of August 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $1,452.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone otic suspension (7.5 mL), with an ultimate completion date of August 5, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999 and extending through December 2026. The prime IDC serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,594.26 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML on May 22, 2025, with an ultimate completion date of May 23, 2025. This firm fixed price delivery order was competitively awarded without any set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Ciprofloxacin-Dexamethasone otic suspension. The $1,336.80 contract has a completion date of March 12, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is the prime contractor. This delivery...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ0P7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,884.78 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5ML) on August 28, 2025, with an ultimate completion date of August 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive IDC with DLA enables it to supply a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems globally. This delivery order exemplifies the company's role in fulfilling routine pharmaceutical supply requirements through the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.9k | 8/28/25 |